EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis

Maria Donata Di Taranto iD, Giuliana Fortunato

International Journal of Molecular Sciences · 06.02.2023 · 24 (4) · 3224

DOI: 10.3390/ijms24043224 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.02.2023. Verfasst von Maria Donata Di Taranto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetics of Familial Hypercholesterolemia (FH) is ascribable to pathogenic variants in genes encoding proteins leading to an impaired LDL uptake by the LDL receptor (LDLR). Two forms of the disease are possible, heterozygous (HeFH) and homozygous (HoFH), caused by one or two pathogenic variants, respectively, in the three main genes that are responsible for the autosomal dominant disease: LDLR, APOB and PCSK9 genes. The HeFH is the most common genetic disease in humans, being the prevalence about 1:300. Variants in the LDLRAP1 gene causes FH with a recessive inheritance and a specific APOE variant was described as causative of FH, contributing to increase FH genetic heterogeneity. In addition, variants in genes causing other dyslipidemias showing phenotypes overlapping with FH may mimic FH in patients without causative variants (FH-phenocopies; ABCG5, ABCG8, CYP27A1 and LIPA genes) or act as phenotype modifiers in patients with a pathogenic variant in a causative gene. The presence of several common variants was also considered a genetic basis of FH and several polygenic risk scores (PRS) have been described. The presence of a variant in modifier genes or high PRS in HeFH further exacerbates the phenotype, partially justifying its variability among patients. This review aims to report the updates on the genetic and molecular bases of FH with their implication for molecular diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Hyperlipoproteinemia Type IIHumansCholesterol, LDLGenetic HeterogeneityPhenotypeReceptors, LDLMutation

Stichwörter der Autor:innen

FH phenocopiesfamilial hypercholesterolemiagenetic heterogeneitygeneticsmodifier factormolecular diagnosisoligogenic FHphenotypic variabilitypolygenic risk score

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLReceptors, LDL

Autor:innen und Institutionen

  • Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
  • CEINGE-Biotecnologie avanzate Franco Salvatore, 80145 Naples, Italy.

ORCID-Profile: Maria Donata Di Taranto

Zitieren

APA

Di Taranto, M. D., & Fortunato, G. (2023). Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis. International Journal of Molecular Sciences, 24(4), 3224. https://doi.org/10.3390/ijms24043224

Vancouver

Di Taranto MD, Fortunato G. Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis. International Journal of Molecular Sciences. 2023;24(4):3224. doi:10.3390/ijms24043224

BibTeX
@article{DiTaranto2023,
  author = {Di Taranto, Maria Donata and Fortunato, Giuliana},
  title = {Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3224},
  doi = {10.3390/ijms24043224}
}
Kostenlos starten →